Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

4.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

24.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

12.0K
12.0K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Novel natural therapies for infectious diseases using computational and pharmacological approaches.

Frontiers in pharmacology·2026
Same author

Editorial: Natural medicines for metabolic diseases - computational and pharmacological approaches, Volume II.

Frontiers in pharmacology·2026
Same author

Hepatoprotective Ergostane and Lanostane Derivatives from Mushrooms for the Management of Metabolic Dysfunction-Associated Fatty Liver Disease: A Review.

International journal of medicinal mushrooms·2026
Same author

Biological effects of essential oil from Pulicaria wightiana (DC.) C.B. Clarke against juvenile stages of three mosquito vectors and its toxicity to mosquito predators.

Journal of vector borne diseases·2025
Same author

Pulmonary Side Effects Associated With Abemaciclib the Antibreast Cancer Drug in Female Mice.

Journal of applied toxicology : JAT·2025
Same author

Understanding low-phosphate stress responses in plants: Opportunities for genome editing to improve phosphorous use efficiency (PUE).

Biotechnology advances·2025

Related Experiment Video

Updated: Apr 2, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.2K

MicroRNA in prostate cancer.

Kasomva Khanmi1, Savarimuthu Ignacimuthu2, Michael Gabriel Paulraj1

  • 1Molecular Biology Unit, Entomology Research Institute, Loyola College, Nungambakkam, Chennai 600 034, India.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|September 30, 2015
PubMed
Summary

This review examines microRNAs (miRNAs) and their role in prostate cancer development. It highlights how these small RNAs impact gene regulation and influence potential clinical therapies for male prostate cancer.

Keywords:
AndrogenMicroRNA (miRNA)Post-transcriptionProstate cancer

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

14.0K

Related Experiment Videos

Last Updated: Apr 2, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.2K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

14.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer (PCa) is a leading malignancy in US males, posing a significant mortality risk.
  • MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression in physiological and pathophysiological processes.

Purpose of the Study:

  • To review the regulation of miRNAs in prostate cancer.
  • To elucidate the mechanisms by which miRNAs contribute to prostate carcinogenesis.
  • To discuss the relationship between miRNAs and androgen signaling in PCa.
  • To explore the therapeutic potential of miRNAs in clinical settings.

Main Methods:

  • Literature review focusing on miRNA regulation in prostate cancer.
  • Analysis of miRNA mechanisms in prostate carcinogenesis.
  • Examination of miRNA interactions with androgen signaling pathways.

Main Results:

  • miRNAs play a crucial role in regulating gene expression relevant to prostate cancer.
  • Specific miRNA dysregulation contributes to the development and progression of prostate cancer.
  • Androgen signaling significantly influences miRNA expression patterns in prostate cancer.

Conclusions:

  • Understanding miRNA regulation is key to deciphering prostate carcinogenesis.
  • miRNAs hold promise as diagnostic biomarkers and therapeutic targets for prostate cancer.
  • Further research into miRNA-androgen signaling interactions could lead to novel treatment strategies.